These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 26880453)
141. GPR68: An Emerging Drug Target in Cancer. Wiley SZ; Sriram K; Salmerón C; Insel PA Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30696114 [TBL] [Abstract][Full Text] [Related]
142. Deletion of proton-sensing receptor GPR4 associates with lower blood pressure and lower binding of angiotensin II receptor in SFO. Sun X; Tommasi E; Molina D; Sah R; Brosnihan KB; Diz D; Petrovic S Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1260-F1266. PubMed ID: 27681561 [TBL] [Abstract][Full Text] [Related]
143. The Roles of Acidosis in Osteoclast Biology. Yuan FL; Xu MH; Li X; Xinlong H; Fang W; Dong J Front Physiol; 2016; 7():222. PubMed ID: 27445831 [TBL] [Abstract][Full Text] [Related]
144. Mechanism of acid-induced bone resorption. Krieger NS; Frick KK; Bushinsky DA Curr Opin Nephrol Hypertens; 2004 Jul; 13(4):423-36. PubMed ID: 15199293 [TBL] [Abstract][Full Text] [Related]
145. Increased bone density in mice lacking the proton receptor OGR1. Krieger NS; Yao Z; Kyker-Snowman K; Kim MH; Boyce BF; Bushinsky DA Kidney Int; 2016 Mar; 89(3):565-73. PubMed ID: 26880453 [TBL] [Abstract][Full Text] [Related]
146. Metabolic acidosis regulates RGS16 and G protein signaling in osteoblasts. Krieger NS; Bushinsky DA Am J Physiol Renal Physiol; 2021 Oct; 321(4):F424-F430. PubMed ID: 34396788 [TBL] [Abstract][Full Text] [Related]
147. Deletion of the proton receptor OGR1 in mouse osteoclasts impairs metabolic acidosis-induced bone resorption. Krieger NS; Chen L; Becker J; Chan MR; Bushinsky DA Kidney Int; 2021 Mar; 99(3):609-619. PubMed ID: 33159961 [TBL] [Abstract][Full Text] [Related]
148. The proton-activated ovarian cancer G protein-coupled receptor 1 (OGR1) is responsible for renal calcium loss during acidosis. Imenez Silva PH; Katamesh-Benabbas C; Chan K; Pastor Arroyo EM; Knöpfel T; Bettoni C; Ludwig MG; Gasser JA; Brandao-Burch A; Arnett TR; Bonny O; Seuwen K; Wagner CA Kidney Int; 2020 May; 97(5):920-933. PubMed ID: 32173037 [TBL] [Abstract][Full Text] [Related]
149. Parathyroid hormone: anabolic and catabolic actions on the skeleton. Silva BC; Bilezikian JP Curr Opin Pharmacol; 2015 Jun; 22():41-50. PubMed ID: 25854704 [TBL] [Abstract][Full Text] [Related]
151. Pharmacological inhibition of intracellular calcium release blocks acid-induced bone resorption. Krieger NS; Bushinsky DA Am J Physiol Renal Physiol; 2011 Jan; 300(1):F91-7. PubMed ID: 21048027 [TBL] [Abstract][Full Text] [Related]
152. Deletion of the pH sensor GPR4 decreases renal acid excretion. Sun X; Yang LV; Tiegs BC; Arend LJ; McGraw DW; Penn RB; Petrovic S J Am Soc Nephrol; 2010 Oct; 21(10):1745-55. PubMed ID: 20798260 [TBL] [Abstract][Full Text] [Related]
153. Abnormalities in osteoclastogenesis and decreased tumorigenesis in mice deficient for ovarian cancer G protein-coupled receptor 1. Li H; Wang D; Singh LS; Berk M; Tan H; Zhao Z; Steinmetz R; Kirmani K; Wei G; Xu Y PLoS One; 2009 May; 4(5):e5705. PubMed ID: 19479052 [TBL] [Abstract][Full Text] [Related]
154. Action of RANKL and OPG for osteoclastogenesis. Kobayashi Y; Udagawa N; Takahashi N Crit Rev Eukaryot Gene Expr; 2009; 19(1):61-72. PubMed ID: 19191757 [TBL] [Abstract][Full Text] [Related]
155. Metabolic acidosis increases intracellular calcium in bone cells through activation of the proton receptor OGR1. Frick KK; Krieger NS; Nehrke K; Bushinsky DA J Bone Miner Res; 2009 Feb; 24(2):305-13. PubMed ID: 18847331 [TBL] [Abstract][Full Text] [Related]